APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+7.92%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$3.7B
AUM Growth
+$3.7B
(+3.2%)
Cap. Flow
+$51.7M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
34.9%
Holding
146
New
53
Increased
24
Reduced
24
Closed
34
Top Buys
| 1 |
Eli Lilly
LLY
|
$130M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$129M |
| 3 |
Hologic
HOLX
|
$80.7M |
| 4 |
Biogen
BIIB
|
$63.7M |
| 5 |
NeoGenomics
NEO
|
$61.7M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$182M |
| 2 |
Intuitive Surgical
ISRG
|
$103M |
| 3 |
AbbVie
ABBV
|
$66.8M |
| 4 |
Avantor
AVTR
|
$64.1M |
| 5 |
Medtronic
MDT
|
$60.7M |
Sector Composition
| 1 | Healthcare | 95.4% |
| 2 | Technology | 1.61% |
| 3 | Financials | 0.67% |
| 4 | Consumer Discretionary | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HARP
51
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $20.8M | 0.56% |
1,500,000
+92,000
| +7% | +$1.28M |
|
52
UiPath
PATH
$5.82B
| $20.4M | 0.55% |
+300,000
| New | +$20.4M |
|
|
GRTS
53
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $19.4M | 0.52% |
2,122,064
| – | – |
|
54
SI-BONE Inc
SIBN
$701M
| $18.1M | 0.49% |
575,000
-2,570
| -0.4% | -$80.9K |
|
55
Zai Lab
ZLAB
$3.66B
| $17.7M | 0.48% |
+100,000
| New | +$17.7M |
|
|
ORTX
56
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $16.6M | 0.45% |
3,781,798
-536,002
| -12% | -$2.35M |
|
57
Aldeyra Therapeutics
ALDX
$352M
| $16.4M | 0.44% |
1,450,000
-1,102,000
| -43% | -$12.5M |
|
|
PHAS
58
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $16.1M | 0.43% |
4,315,000
+30,000
| +0.7% | +$112K |
|
|
SYNH
59
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $15.7M | 0.42% |
+175,000
| New | +$15.7M |
|
60
Sana Biotechnology
SANA
$736M
| $15.3M | 0.41% |
778,597
+46,276
| +6% | +$910K |
|
61
SCYNEXIS
SCYX
$34.8M
| $15.2M | 0.41% |
2,060,000
+796,231
| +63% | +$5.86M |
|
|
ALPN
62
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $13.5M | 0.36% |
1,495,000
-16,000
| -1% | -$144K |
|
|
BLU
63
DELISTED
BELLUS Health Inc.
BLU
| $13.2M | 0.36% |
4,250,000
-2,547,400
| -37% | -$7.92M |
|
64
AC Immune
ACIU
$224M
| $12.6M | 0.34% |
+1,584,000
| New | +$12.6M |
|
65
GH Research
GHRS
$857M
| $12.2M | 0.33% |
+560,000
| New | +$12.2M |
|
66
Nautilus Biotechnolgy
NAUT
$84.3M
| $11.4M | 0.31% |
1,125,000
+625,000
| +125% | +$6.31M |
|
67
Werewolf Therapeutics
HOWL
$60.4M
| $11.3M | 0.31% |
+650,265
| New | +$11.3M |
|
68
Zeta Global
ZETA
$4.53B
| $10.9M | 0.3% |
+1,300,000
| New | +$10.9M |
|
|
CMAX
69
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $10.5M | 0.29% |
+817,402
| New | +$10.5M |
|
70
Prothena Corp
PRTA
$447M
| $9.36M | 0.25% |
+182,000
| New | +$9.36M |
|
71
Cardiff Oncology
CRDF
$132M
| $9.28M | 0.25% |
1,395,000
-1,052,700
| -43% | -$7M |
|
72
monday.com
MNDY
$9.67B
| $8.94M | 0.24% |
+40,000
| New | +$8.94M |
|
|
ISEE
73
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.83M | 0.24% |
+1,400,010
| New | +$8.83M |
|
74
Doximity
DOCS
$12.6B
| $8.73M | 0.24% |
+150,000
| New | +$8.73M |
|
75
Arrowhead Research
ARWR
$3.72B
| $8.61M | 0.23% |
+104,000
| New | +$8.61M |
|